ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Combined Blockade of Lipid Uptake and Synthesis by CD36 Inhibitor and SCD1 siRNA Is Beneficial for the Treatment of Refractory Prostate Cancer.

Jiyuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.